Descamps B
Nouv Presse Med. 1978 Feb 11;7(6):457-62.
This study, based on results of 252 cadaver kidney transplantations, shows that some factors which reflect individual immune response capacity, such as ability to produce anti-HLA antibodies, sex and response to hepatitis B virus, appear, along with HLA compatibility, to markedly influence renal graft survival and leads us to propose the following new guide-line for cadaver kidney recipient selection: For "good responders" (i.e., patients with anti-HLA antibodies, females and HBs Ag negative individuals) a close HLA compatibility with the donor (3 or 4 antigens in common) is necessary, while this need not be observed for "non-responders" (i.e., patients without preformed anti-HLA antibodies, males and HBs Ag persistent carriers). Furthermore, review of recent methods proposed for detecting early cellular and humoral manifestations of rejection leads to proposal of the following immunological monitoring of the transplant recipient. Systematic and frequent testing for circulating cytotoxic cells and antibodies against donor antigens, regular dosage of complement factors and of the nephretic factor, and investigations for the migration leukocyte inhibiting factor and macrophage arming factor, possibly produced in vitro by lymphocytes. Both these protocols for recipient selection and immunological monitoring can henceforth be applied and may contribute to improve cadaver kidney transplantation prognosis.
这项基于252例尸体肾移植结果的研究表明,一些反映个体免疫反应能力的因素,如产生抗HLA抗体的能力、性别和对乙肝病毒的反应,与HLA相容性一起,似乎对肾移植存活有显著影响,并促使我们提出以下新的尸体肾受体选择指南:对于“反应良好者”(即有抗HLA抗体的患者、女性和HBs Ag阴性个体),与供体密切的HLA相容性(有3或4个共同抗原)是必要的,而对于“无反应者”(即没有预先形成的抗HLA抗体的患者、男性和HBs Ag持续携带者)则无需遵循此点。此外,对最近提出的用于检测排斥反应早期细胞和体液表现的方法进行回顾,促使我们提出以下对移植受体的免疫监测方法。系统且频繁地检测循环中的细胞毒性细胞和针对供体抗原的抗体,定期测定补体因子和肾病因子的剂量,并检测可能由淋巴细胞在体外产生的迁移白细胞抑制因子和巨噬细胞武装因子。因此,这两种受体选择和免疫监测方案今后均可应用,可能有助于改善尸体肾移植的预后。